CL2007002673A1 - Compuesto de aziridina para marcacion; metodo que prepara dicho compuesto, compuesto fluorado con fluor radioactivo; metodo que prepara el compuesto fluorado; composicion que comprende el compuesto de aziridina o el compuesto fluorado; uso del compue - Google Patents
Compuesto de aziridina para marcacion; metodo que prepara dicho compuesto, compuesto fluorado con fluor radioactivo; metodo que prepara el compuesto fluorado; composicion que comprende el compuesto de aziridina o el compuesto fluorado; uso del compueInfo
- Publication number
- CL2007002673A1 CL2007002673A1 CL200702673A CL2007002673A CL2007002673A1 CL 2007002673 A1 CL2007002673 A1 CL 2007002673A1 CL 200702673 A CL200702673 A CL 200702673A CL 2007002673 A CL2007002673 A CL 2007002673A CL 2007002673 A1 CL2007002673 A1 CL 2007002673A1
- Authority
- CL
- Chile
- Prior art keywords
- compound
- fluorated
- prepares
- aziridine
- compue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- C07D203/24—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07090001A EP1944288A1 (en) | 2007-01-09 | 2007-01-09 | Radiolabelling via fluorination of aziridines |
| EP07090079A EP1985624A3 (en) | 2007-04-23 | 2007-04-23 | Single step method of radiofluorination of biologically active compounds or biomolecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2007002673A1 true CL2007002673A1 (es) | 2008-07-18 |
Family
ID=38941926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200702673A CL2007002673A1 (es) | 2007-01-09 | 2007-09-14 | Compuesto de aziridina para marcacion; metodo que prepara dicho compuesto, compuesto fluorado con fluor radioactivo; metodo que prepara el compuesto fluorado; composicion que comprende el compuesto de aziridina o el compuesto fluorado; uso del compue |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20090022664A1 (es) |
| EP (1) | EP2099747A1 (es) |
| JP (1) | JP2010522140A (es) |
| KR (1) | KR20090096716A (es) |
| AR (1) | AR062856A1 (es) |
| AU (1) | AU2007343454A1 (es) |
| BR (1) | BRPI0720884A2 (es) |
| CA (1) | CA2674408A1 (es) |
| CL (1) | CL2007002673A1 (es) |
| CO (1) | CO6220852A2 (es) |
| CR (1) | CR10917A (es) |
| DO (1) | DOP2009000173A (es) |
| EC (1) | ECSP099505A (es) |
| MA (1) | MA31175B1 (es) |
| MX (1) | MX2009007395A (es) |
| NO (1) | NO20092813L (es) |
| PA (1) | PA8747801A1 (es) |
| PE (1) | PE20081661A1 (es) |
| RU (1) | RU2009130455A (es) |
| SV (1) | SV2009003328A (es) |
| TN (1) | TN2009000233A1 (es) |
| TW (1) | TW200829275A (es) |
| UY (1) | UY30594A1 (es) |
| WO (1) | WO2008083729A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8784774B2 (en) | 2011-09-16 | 2014-07-22 | General Electric Company | Labeled molecular imaging agents and methods of use |
| US9468693B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
| US9468692B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
| NL2014828B1 (en) * | 2015-05-20 | 2017-01-31 | Out And Out Chemistry S P R L | Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3954994A (en) * | 1968-10-03 | 1976-05-04 | Pfizer Inc. | Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents |
| JPS5810380B2 (ja) * | 1975-01-31 | 1983-02-25 | 三共株式会社 | ペプチドノ セイホウ |
| US6015790A (en) * | 1997-10-06 | 2000-01-18 | Basf Aktiengesellschaft | Methods and compositions for treating rheumatoid arthritis |
| DE60043616D1 (de) * | 1999-07-21 | 2010-02-11 | Univ Pennsylvania | Herstellung von verbindungen zur bestimmung der hypoxie |
| SE9903998D0 (sv) * | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
| US6894057B2 (en) * | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| WO2004014377A1 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| GB0222909D0 (en) * | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
| US6875784B2 (en) * | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
| CN1212307C (zh) * | 2003-07-23 | 2005-07-27 | 中国科学院上海有机化学研究所 | 一种合成β－氟胺化合物的方法 |
| CA2580461A1 (en) * | 2004-09-23 | 2006-04-06 | Amgen Inc. | Substituted sulfonamidopropionamides and methods of use |
| US7629373B2 (en) * | 2005-04-07 | 2009-12-08 | Merck & Co. Inc. | Mitotic kinesin inhibitors |
-
2007
- 2007-09-07 WO PCT/EP2007/007968 patent/WO2008083729A1/en active Application Filing
- 2007-09-07 BR BRPI0720884-7A patent/BRPI0720884A2/pt not_active IP Right Cessation
- 2007-09-07 RU RU2009130455/04A patent/RU2009130455A/ru not_active Application Discontinuation
- 2007-09-07 EP EP07802294A patent/EP2099747A1/en not_active Withdrawn
- 2007-09-07 JP JP2009545069A patent/JP2010522140A/ja active Pending
- 2007-09-07 US US11/851,786 patent/US20090022664A1/en not_active Abandoned
- 2007-09-07 MX MX2009007395A patent/MX2009007395A/es unknown
- 2007-09-07 CA CA002674408A patent/CA2674408A1/en not_active Abandoned
- 2007-09-07 KR KR1020097014304A patent/KR20090096716A/ko not_active Application Discontinuation
- 2007-09-07 AU AU2007343454A patent/AU2007343454A1/en not_active Abandoned
- 2007-09-10 TW TW096133836A patent/TW200829275A/zh unknown
- 2007-09-14 UY UY30594A patent/UY30594A1/es not_active Application Discontinuation
- 2007-09-14 AR ARP070104087A patent/AR062856A1/es unknown
- 2007-09-14 PA PA20078747801A patent/PA8747801A1/es unknown
- 2007-09-14 CL CL200702673A patent/CL2007002673A1/es unknown
- 2007-09-14 PE PE2007001247A patent/PE20081661A1/es not_active Application Discontinuation
-
2009
- 2009-06-08 TN TNP2009000233A patent/TN2009000233A1/fr unknown
- 2009-07-08 DO DO2009000173A patent/DOP2009000173A/es unknown
- 2009-07-09 CR CR10917A patent/CR10917A/es unknown
- 2009-07-09 CO CO09071219A patent/CO6220852A2/es not_active Application Discontinuation
- 2009-07-09 EC EC2009009505A patent/ECSP099505A/es unknown
- 2009-07-09 SV SV2009003328A patent/SV2009003328A/es not_active Application Discontinuation
- 2009-08-06 MA MA32154A patent/MA31175B1/fr unknown
- 2009-08-07 NO NO20092813A patent/NO20092813L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2099747A1 (en) | 2009-09-16 |
| SV2009003328A (es) | 2009-12-14 |
| JP2010522140A (ja) | 2010-07-01 |
| RU2009130455A (ru) | 2011-02-20 |
| CA2674408A1 (en) | 2008-07-17 |
| ECSP099505A (es) | 2009-08-28 |
| TW200829275A (en) | 2008-07-16 |
| CR10917A (es) | 2009-08-27 |
| KR20090096716A (ko) | 2009-09-14 |
| AU2007343454A1 (en) | 2008-07-17 |
| AR062856A1 (es) | 2008-12-10 |
| PE20081661A1 (es) | 2009-01-18 |
| US20090022664A1 (en) | 2009-01-22 |
| DOP2009000173A (es) | 2010-10-31 |
| MA31175B1 (fr) | 2010-02-01 |
| BRPI0720884A2 (pt) | 2014-03-25 |
| PA8747801A1 (es) | 2009-08-26 |
| TN2009000233A1 (en) | 2010-10-18 |
| CO6220852A2 (es) | 2010-11-19 |
| NO20092813L (no) | 2009-09-22 |
| MX2009007395A (es) | 2009-07-17 |
| UY30594A1 (es) | 2008-09-02 |
| WO2008083729A1 (en) | 2008-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2012003415A1 (es) | Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer . | |
| CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
| CL2007003138A1 (es) | Compuestos derivados de anilinopiperazina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
| BR112016000489A2 (pt) | composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos | |
| CL2014002100A1 (es) | Compuestos biciclicos nitrogenados; composicion farmaceutica que los comprende y uso para el tratamiento de la atrofia muscular espinal. | |
| CL2016001911A1 (es) | Compuesto heterocíclico fusionado | |
| CL2014002093A1 (es) | Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas. | |
| BR112015012662A2 (pt) | processo para a preparação de uma composição aceleradora de endurecimento,composição aceleradora de endurecimento, uso da mesma e misturas de material de construção contendo uma composição aceleradora de endurecimento. | |
| CL2008002521A1 (es) | Compuestos derivados de pirazol sustituidos, antagonista del receptor de androgeno; composicion farmaceutica que comprende a dichos compuestos; y uso del compusto para el tratamiento de cancer. | |
| CL2007003202A1 (es) | Compuestos derivados de espiroindolinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos de proliferacion celular. | |
| CL2011000191A1 (es) | Compuestos derivados de pirimidina fusionada sustituida,inhibidores de mtor; composicion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
| CL2007000311A1 (es) | Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende;y su uso en el trastamiento de un trastorno proliferativos como es el cancer. | |
| BR112014028755A2 (pt) | composição de argamassa de poliuretano, processo para preparação da composição de argamassa de poliuretano, e, uso de uma composição de argamassa de poliuretano. | |
| UY30595A1 (es) | Métodos de marcacion con fluor radioactivo | |
| CL2008000224A1 (es) | Composicion farmaceutica que comprende un compuesto derivado glucopiranosilo; y uso para el tratamiento de uno o mas trastornos neurodegenerativos. | |
| CL2008000793A1 (es) | Compuestos derivados de dihidroindazol; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno del hierro. | |
| GT201700023A (es) | Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias | |
| BRPI0818544A2 (pt) | Processo para tratamento de uma combinação contendo organossilano, composição e uso de uma resina orgânica. | |
| CL2008002708A1 (es) | Compuestos derivados de azaciclilisoquinolinona e isoindolinona, antagonistas de histamina-3; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuestos; y uso del compuesto para el tratamiento de un trastorno cognitivo, | |
| CL2011001331A1 (es) | Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo. | |
| CL2015000976A1 (es) | Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados. | |
| BR112018002983A2 (pt) | composição compreendendo uma lactama e um álcool | |
| CL2008000440A1 (es) | Compuestos derivados de 4-aril-3-piridazina, antagonistas del receptor de dopamina 2 de rapida disociacion; composicion farmaceutica que comprende a dichos compuestos; y su uso como antipsicotico para el tratamiento o prevencion de la esquizofrenia, | |
| CL2017002214A1 (es) | Formulación de combinación de tesofensina y betabloqueante | |
| CL2008000110A1 (es) | Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos. |